FDA said they screwed the pooch on the documentation of the actual drug material used at one or more of the test sites, as best I can tell so far. Seems the FDA could not confirm exactly which form of the drug was used, or some such nonsense. ANX is planning to request a hearing of some sort to try an counter the FDA decision, but no one so far seems to believe the FDA will change their mind.
The stock is selling for less than cash in the bank, with a sort of limbo (but not looked at all good) status on the current drug application. FDA says they need to redo the trials (OUCH). They still have 2 other drugs in the pipeline, but all will burn cash at this point, so cash value per share is going to go down, or share count will rise soon. Someone posted some info on the ANX COB (seems he is also the COB of another biotech that is being sued for defrauding investors).
I am still holding all my shares. No sense selling here.
News 
Market Data 
Discover 
